Previous studies in ovarian cancer cells have reported on the transcriptional regulation of HER2 and HER3 by NRF2 and showed associations between NRF2 function, HER2/HER3 signalling, reactive oxygen species (ROS) generation and glutathione depletion [40, 41]. This evidence concerns the gene NFE2L2 and ovarian cancer.